Does UnitedHealthcare Cover Symbicort?

Yes. Generic budesonide/formoterol is the preferred, covered inhaler via OptumRx on most UHC commercial and Medicare Part D plans, typically at a lower preferred tier. OptumRx has consistently favored the generic over brand Symbicort since the generic became widely available. This is the covered path UHC intends.

Brand Symbicort is frequently non-preferred on UHC commercial plans and is often not covered at all on UHC Medicare Part D formularies via OptumRx. Because the generic is therapeutically equivalent and far less expensive, OptumRx places brand Symbicort on a high non-preferred tier or removes it entirely. Verify on the OptumRx drug-lookup tool whether your specific plan covers brand Symbicort.

Symbicort has a generic (budesonide/formoterol) that OptumRx prefers — brand is commonly excluded. Trelegy Ellipta is brand-only; no generic exists, so UHC covers it as a brand inhaler with possible step therapy. The coverage question for Symbicort is generic-vs-brand; for Trelegy it is prior-auth/step-therapy on the brand. Same PBM, opposite inhaler-coverage logic.

UHC Community Plan (Medicaid) covers generic budesonide/formoterol per state Preferred Drug Lists, with nominal Medicaid cost-share. Brand Symbicort typically requires prior authorization or step therapy under Medicaid managed care. Coverage details vary by state; verify on your specific UHC Community Plan drug list or by calling UHC Medicaid member services.

Step therapy requires trying a simpler, less expensive inhaler — typically an ICS alone like generic fluticasone — before an ICS/LABA combination such as generic budesonide/formoterol is approved. If your asthma or COPD requires combination therapy, your prescriber can document why a step-down is not appropriate. Step therapy is not universal across UHC plans; verify on the OptumRx formulary.